AHL Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AHL Investment Management's PFE Position: Q3 2025 in Review
AHL Investment Management increased its Pfizer (PFE) stake by 5.7% in Q3 2025, buying an estimated $134K and bringing the position to 100,112 shares worth $2.55M. The position accounts for 1.74% of the portfolio, ranked #22.
AHL Investment Management first reported a position in PFE in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.91M in Q4 2021. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- AHL Investment Management held 100,112 shares of Pfizer worth $2.55M as of Q3 2025.
- AHL Investment Management bought 5,410 Pfizer shares in Q3 2025, an estimated $134K.
- Pfizer made up 1.74% of AHL Investment Management's portfolio in Q3 2025, its #22 holding.
- AHL Investment Management first reported a position in Pfizer in Q4 2021 and has held it in 16 quarters since.
- AHL Investment Management's Pfizer position peaked at $2.91M in Q4 2021.
- 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on AHL Investment Management's 13F filing for Q3 2025, filed 2 Oct 2025.